Application Information

This drug has been submitted to the FDA under the reference 089166/001.

Names and composition

"SYNALGOS-DC-A" is the commercial name of a drug composed of ACETAMINOPHEN and CAFFEINE and DIHYDROCODEINE BITARTRATE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
089166/001 SYNALGOS-DC-A ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE CAPSULE/ORAL 356.4MG and 30MG and 16MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
040109/001 ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE CAPSULE/ORAL 356.4MG and 30MG and 16MG
040316/001 ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE TABLET/ORAL 712.8MG and 60MG and 32MG
040637/001 ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE TABLET/ORAL 712.8MG and 60MG and 32MG
040688/001 ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE CAPSULE/ORAL 356.4MG and 30MG and 16MG
040701/001 ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE TABLET/ORAL 712.8MG and 60MG and 32MG
088584/001 DHC PLUS ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE CAPSULE/ORAL 356.4MG and 30MG and 16MG
089166/001 SYNALGOS-DC-A ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE CAPSULE/ORAL 356.4MG and 30MG and 16MG
204209/001 ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE TABLET/ORAL 325MG and 30MG and 16MG
204785/001 TREZIX ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE CAPSULE/ORAL 320.5MG and 30MG and 16MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved